Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/26493
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLill J.K.en
dc.contributor.authorPohl J.-M.en
dc.contributor.authorBottek J.en
dc.contributor.authorSubramaniam N.en
dc.contributor.authorChrist R.en
dc.contributor.authorSoun C.en
dc.contributor.authorGueler F.en
dc.contributor.authorZwanziger D.en
dc.contributor.authorHoffmann F.en
dc.contributor.authorvon Eggeling F.en
dc.contributor.authorBracht T.en
dc.contributor.authorSitek B.en
dc.contributor.authorHickey M.J.en
dc.contributor.authorHofnagel O.en
dc.contributor.authorEngel D.R.en
dc.contributor.authorThiebes S.en
dc.date.accessioned2021-05-14T08:47:56Zen
dc.date.available2021-05-14T08:47:56Zen
dc.date.copyright2021en
dc.date.created20210510en
dc.date.issued2021-05-10en
dc.identifier.citationKidney international. (no pagination), 2021. Date of Publication: 27 Apr 2021.en
dc.identifier.issn1523-1755 (electronic)en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/26493en
dc.description.abstractEnterohaemorrhagic E. coli cause major epidemics worldwide with significant organ damage and very high percentages of death. Due to the ability of enterohaemorrhagic E. coli to produce shiga toxin these bacteria damage the kidney leading to the hemolytic uremic syndrome. A therapy against this serious kidney disease has not been developed yet and the impact and mechanism of leukocyte activation and recruitment are unclear. Tissue-resident macrophages represent the main leukocyte population in the healthy kidney, but the role of this important cell population in shiga toxin-producing E. coli-hemolytic uremic syndrome is incompletely understood. Using state of the art microscopy and mass spectrometry imaging, our preclinical study demonstrated a phenotypic and functional switch of tissue-resident macrophages after disease induction in mice. Kidney macrophages produced the inflammatory molecule TNFalpha and depletion of tissue-resident macrophages via the CSF1 receptor abolished TNFalpha levels in the kidney and significantly diminished disease severity. Furthermore, macrophage depletion did not only attenuate endothelial damage and thrombocytopenia, but also activation of thrombocytes and neutrophils. Moreover, we observed that neutrophils infiltrated the kidney cortex and depletion of macrophages significantly reduced the recruitment of neutrophils and expression of the neutrophil-attracting chemokines CXCL1 and CXCL2. Intravital microscopy revealed that inhibition of CXCR2, the receptor for CXCL1 and CXCL2, significantly reduced the infiltration of neutrophils and reduced kidney injury. Thus, our study shows activation of tissue-resident macrophages during shiga toxin-producing E. coli-hemolytic uremic syndrome leading to the production of disease-promoting TNFalpha and CXCR2-dependent recruitment of neutrophils.Copyright © 2021. Published by Elsevier Inc.en
dc.languageenen
dc.languageEnglishen
dc.publisherNLM (Medline)en
dc.relation.ispartofKidney International-
dc.titleTissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.kint.2021.03.039en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid33930412 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33930412]en
dc.identifier.source634942465en
dc.identifier.institution(Lill) Department of Immunodynamics, Institute of Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany; Leibniz Institut fur Analytische Wissenschaften - ISAS - e.V., Dortmund, Germany (Thiebes, Pohl, Bottek, Subramaniam, Christ, Soun, Engel) Department of Immunodynamics, Institute of Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany (Gueler) Department of Nephrology, Hannover Medical School, Hannover, Germany (Zwanziger) Department of Endocrinology, Diabetes and Metabolism and Clinical Chemistry, Division of Laboratory Research, University of Duisburg-Essen, Essen, Germany (Hoffmann, von Eggeling) Department of Otorhinolaryngology, Jena University Hospital, Jena 07743, Germany (Bracht) Ruhr University Bochum, Medical Faculty, Medizinisches Proteom-Center, 44801 Bochum, Germany; Klinik fur Anasthesiologie, Intensivmedizin und Schmerztherapie, Universitatsklinikum Knappschaftskrankenhaus Bochum, 44892 Bochum, Germany (Sitek) Ruhr University Bochum, Medical Faculty, Medizinisches Proteom-Center, Bochum 44801, Germany (Hickey) Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, VIC, Australia (Hofnagel) Max Planck Institute of Molecular Physiology, Dortmund, Germanyen
dc.description.publicationstatusArticle-in-Pressen
dc.rights.statementThis record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicineen
dc.subect.keywordsEnterohaemorrhagic E. coli, Macrophages Mass spectrometry imaging Microscopyen
dc.identifier.authoremailEngel D.R.; engel@immunodynamics.deen
dc.identifier.affiliationext(Lill) Department of Immunodynamics, Institute of Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany; Leibniz Institut fur Analytische Wissenschaften - ISAS - e.V., Dortmund, Germany-
dc.identifier.affiliationext(Thiebes, Pohl, Bottek, Subramaniam, Christ, Soun, Engel) Department of Immunodynamics, Institute of Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany-
dc.identifier.affiliationext(Gueler) Department of Nephrology, Hannover Medical School, Hannover, Germany-
dc.identifier.affiliationext(Zwanziger) Department of Endocrinology, Diabetes and Metabolism and Clinical Chemistry, Division of Laboratory Research, University of Duisburg-Essen, Essen, Germany-
dc.identifier.affiliationext(Hoffmann, von Eggeling) Department of Otorhinolaryngology, Jena University Hospital, Jena 07743, Germany-
dc.identifier.affiliationext(Bracht) Ruhr University Bochum, Medical Faculty, Medizinisches Proteom-Center, 44801 Bochum, Germany; Klinik fur Anasthesiologie, Intensivmedizin und Schmerztherapie, Universitatsklinikum Knappschaftskrankenhaus Bochum, 44892 Bochum, Germany-
dc.identifier.affiliationext(Sitek) Ruhr University Bochum, Medical Faculty, Medizinisches Proteom-Center, Bochum 44801, Germany-
dc.identifier.affiliationext(Hofnagel) Max Planck Institute of Molecular Physiology, Dortmund, Germany-
dc.identifier.affiliationmh(Hickey) Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, VIC, Australia-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
Appears in Collections:Articles
Show simple item record

Page view(s)

188
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.